X4 Pharmaceuticals, (XFOR) Institutional Ownership
Track institutional investors, ownership changes, and 13F filings.
Ownership Summary
Total Institutions
95
Total Shares Held
99.82M
Total Value
$73.24M
Institutional Holding %
49.70%
Ownership Distribution
Top 5 Holders
Top Institutional Holders (as of Dec 31, 2024)
| Institution | Shares | Ownership % | Value |
|---|---|---|---|
| BAIN LIFE SCIENCES INVESTORS | 16.92M | 8.42% | $12.41M |
| NEA COMPANY | 14.99M | 7.46% | $10.99M |
| BlackRock | 11.06M | 5.51% | $8.11M |
| VANGUARD | 8.20M | 4.08% | $6.02M |
| 7.31M | 3.64% | $5.36M | |
| ORBIMED | 7.13M | 3.55% | $5.23M |
| KINGDON, L.L.C. | 4.94M | 2.46% | $3.62M |
| GEODE | 3.50M | 1.74% | $2.57M |
| AXA S.A. | 3.07M | 1.53% | $2.25M |
| STATE STREET | 3.06M | 1.52% | $2.24M |
Recent Insider Trading
| Insider | Title | Transaction | Shares | Value | Date |
|---|---|---|---|---|---|
| Arbet-Engels Christophe | Chief Medical Officer | A-Award | 850.00K | $- | Feb 12, 2025 |
| Mostafa Adam S. | Chief Financial Officer | A-Award | 850.00K | $- | Feb 12, 2025 |
| Ragan Paula | Director, President And Ceo | A-Award | 2.25M | $- | Feb 12, 2025 |
| Baldry Mark | Chief Commercial Officer | A-Award | 600.00K | $- | Feb 12, 2025 |
| Baldry Mark | Chief Commercial Officer | P-Purchase | 13.40K | $4.60K | Nov 15, 2024 |
| Baldry Mark | Chief Commercial Officer | P-Purchase | 21.65K | $14.65K | May 17, 2024 |
| Dibiase Mary | Chief Operating Officer | A-Award | 650.00K | $- | Feb 12, 2025 |
| Ragan Paula | Director, President And Ceo | A-Award | 169.94K | $- | Jan 23, 2025 |
| Ragan Paula | Director, President And Ceo | S-Sale | 76.47K | $34.72K | Jan 24, 2025 |
| Mostafa Adam S. | Chief Financial Officer | A-Award | 74.77K | $- | Jan 23, 2025 |
Recent Position Changes
| Institution | Shares Changed | % Change | Date |
|---|---|---|---|
| +7.31M | +100.00% | Feb 14, 2025 | |
| SUSQUEHANNA, LLP | +1.71M | +992.29% | Feb 14, 2025 |
| GSA LLP | +765.94K | +150.87% | Feb 07, 2025 |
| GROUP ONE TRADING | +671.91K | +535.37% | Feb 14, 2025 |
| UBS | +661.93K | +253.49% | Feb 14, 2025 |
| SCHONFELD STRATEGIC | -527.97K | -27.49% | Feb 14, 2025 |
| JPMorgan CHASE | +383.18K | +501.04% | Feb 12, 2025 |
| JANE STREET | +335.04K | +134.85% | Feb 14, 2025 |
| KINGDON, L.L.C. | +298.32K | +6.43% | Feb 14, 2025 |
| UBS OCONNOR | -285.00K | -18.39% | Feb 14, 2025 |
Recent Ownership Filings
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 27, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 27, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 27, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 27, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 27, 2025
144
Form 144 - Report of proposed sale of securities
Jan 24, 2025
144
Form 144 - Report of proposed sale of securities
Jan 24, 2025
144
Form 144 - Report of proposed sale of securities
Jan 24, 2025
144
Form 144 - Report of proposed sale of securities
Jan 24, 2025
144
Form 144 - Report of proposed sale of securities
Jan 24, 2025
144
Form 144 - Report of proposed sale of securities
Jan 24, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Nov 19, 2024
144
Form 144 - Report of proposed sale of securities
Nov 15, 2024
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 04, 2024
Related Metrics
Explore detailed financial metrics and analysis for XFOR.